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Nitric oxideWe investigated whether the vasopressin (AVP) secretion deﬁciency observed during cecal ligation and
puncture (CLP)-induced sepsis may be caused by apoptosis in hypothalamic magnocellular neurons. Plasma
cytokines (TNF-α, IL-1β and IL-6) and nitrate levels were increased during sepsis and plasma AVP levels were
higher in the early phase returning to basal levels in the late phase. Concomitantly, expression of the apopto-
sis effector, cleaved caspase 3, was increased in magnocellular neurons, inferring that this increase in hypo-
thalamic neurons may be caused by cytokines and elevated nitrate levels. This in turn could compromise AVP
secretion in the late phase of sepsis.
© 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Sepsis is a systemic inﬂammatory response that results from a
complex interaction between host and infectious agent (Bone et al.,
1992; Vincent and Korkut, 2008) leading to excessive production and
release of inﬂammatory mediators that may directly or indirectly acti-
vate the central nervous system causing encephalopathy and affecting
certain body functions, including hormone secretion (McCann et al.,
2000; Kovacs, 2002; Sharshar et al., 2004; Semmler et al., 2005; Berg
et al., 2011).
Among the neuroendocrine changes occurring during sepsis, the
biphasic response of vasopressin (AVP) secretion has been extensively
studied (Landry et al., 1997; Sharshar et al., 2003a; Correa et al., 2007;
Oliveira-Pelegrin et al., 2009, 2010a, 2010b). AVP is a neurohypophy-
seal hormone synthesized in magnocellular neurons of the supraoptic
(SON) and paraventricular (PVN) nuclei of the hypothalamus. The in-
crease in AVP plasma levels commonly denoted in the initial phase of
sepsis is considered an attempt to revert the drop in blood pressure.
Yet in the late phase, AVP secretion is inappropriately low, this con-
tributing to vasodilatation and organ dysfunction.Faculdade de Odontologia de
904 Ribeirão Preto-SP, Brazil.
.
ng für Neuropharmakologie,
y.
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in the late phase of polymicrobial sepsis we observed several factors
that apparently contribute to this syndrome, such as a decrease in
AVP gene expression (Oliveira-Pelegrin et al., 2010b), a change in hy-
pothalamic hormone content, and also an inability to replenish the
neurohypophyseal stocks of AVP (Oliveira-Pelegrin et al., 2009). Addi-
tionally, a reduction or blockage of neuronal activation in different
brain region related to autonomic and neuroendocrine functions has
also been observed in septic animals (Correa et al., 2007; Bruhn et
al., 2009). Taken together, these ﬁndings suggested that neuronal
impairment may occur in the late phase of sepsis, and this hypothesis
is in line with observations in patients that died due to sepsis and
which evidenced neuronal and glial apoptosis in regions related to
autonomic functions were observed (Sharshar et al., 2003b).
Apoptosis, an ATP-dependent mechanism, can be triggered by
various stimuli that induce extrinsic and/or intrinsic death signaling
pathways (Bantel and Schulze-Osthoff, 2009). These pathways lead
to the activation of apoptotic effector caspases, with caspase-3 being
one of the most important ones, although neither unique nor ubiqui-
tous. Caspase-3 activation results in cleavage of key protein in the
apoptosis process (Mignotte and Vayssiere, 1998; Porter and Janicke,
1999).
During sepsis the brain is exposed to several stimuli that can trig-
ger apoptosis pathways (Semmler et al., 2005; Alexander et al., 2008;
Berg et al., 2011). To understand their effects we herein investigated
the activation of caspase-3 in hypothalamic magnocellular neurons
during experimental polymicrobial sepsis.
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2.1. Animals
Male Wistar rats (250 ± 30 g) provided by the Animal Facility of
the Campus of Ribeirão Preto, University of São Paulo, were housed
in controlled temperature (25 ± 1 °C) and photoperiodic (12:12 h
night:day cycle) conditions, with food (Nuvilab CR-1, NUVITAL) and
tap water available ad libitum. All experimental protocols were ap-
proved and performed according to the guidelines of the Ethics Com-
mittee of the University of São Paulo - Campus Ribeirão Preto. Humane
endpoints in shock research (Nemzek et al., 2004) were used as crite-
rion to euthanize CLP-animals in high suffering, immediately before or
soon after the studied time-points deﬁned in this study.2.2. Cecal ligation and puncture surgery
Animals were randomly assigned to one of two groups, CLP group
and sham-operated or non-manipulated animals (control). All exper-
iments were performed at the same time of day (08:00–10:00 AM).
Induction of severe sepsis was performed by a cecal ligation and
puncture (CLP) procedure. Brieﬂy, rats were anesthetized with a
short-acting anesthetic agent (tribromoethanol; 2.5%, 250 mg/
kg i.p.; Acros Organics) in order to minimize deleterious effects of an-
esthesia on cardiovascular functions. Under sterile surgical conditions
the animals were subjected to a midline laparotomy. The cecum was
carefully isolated to avoid damage to the blood vessels. Subsequently,
the cecum was ligated below the ileocecal valve, without causing
bowel obstruction, and punctured ten times with a 16-gauge needle
allowing fecal contents to spill into the peritoneum. The abdominal
cavity was closed in two layers, and all animals received a subcutane-
ous injection of saline (20 mL/kg body weight). Sham-operated ani-
mals were submitted to laparotomy, the cecum was manipulated but
neither ligated nor punctured. The animals were allowed to recover
in their cages with free access to food and water.2.3. Experimental protocol
Following sham-operation or CLP surgery, the animalswere decap-
itated at 4, 6, 24 or 48 h for blood collection and removal of the brain.
Plasma was used for measurement of cytokines, nitric oxide (NO) and
AVP levels. Brains were snap-frozen on dry ice and stored at −80 °C
until SON and PVN dissection. These hypothalamic nuclei were care-
fully microdissected and processed for reverse transcription (RT)
and quantitative polymerase chain reaction (qPCR) for caspase-3 tran-
script levels, or Western blotting for detection of cleaved caspase-3
(CC3) protein. Another set of animals was deeply anesthetized and
perfused with 4% paraformaldehyde (4% PFA) in 0.1 M phosphate
buffered saline (0.1 M PBS) at 6 and 24 h after surgery. Brains were
removed, post-ﬁxed for 4 h and immersed in 30% sucrose in PBS for
cryoprotection. Cryostat sections of 30 μm thickness containing the
hypothalamus were processed for CC3 immunohistochemistry.2.4. Measurement of plasma cytokine levels
Plasma was used for measuring TNF-α, IL-1β and IL-6 levels by
using kits for speciﬁc enzyme-linked immunosorbent assay (DuoSet
ELISA Development system) (R&D Systems, Minneapolis, MN, USA).
The assays were performed following the manufacturer's instructions
and the detection limits for TNF-α, IL-1β and IL-6 were 5, 5 and
21 pg/mL, respectively. According to the manufacturer's datasheet,
the TNF-α, IL-1β and IL-6 assays do not exhibit any cross-reactivity
or interference.2.5. Plasma nitrate quantiﬁcation
Total nitrate was determined by using the purge system of a
Sievers Instruments Nitric Oxide Analyzer (NOA model 280i, Boulder,
CO, USA). Plasma samples were deproteinized using cold absolute
ethanol and then injected into a reaction vessel containing vanadium
trichloride (VCl3), which converts nitrate to NO. The NO producedwas
detected as ozone induced by chemiluminescence. Peak NO values of
samples were determined using a standard curve established with
sodium nitrate solutions of various concentrations (5, 10, 25, 50 and
100 μM).
2.6. Radioimmunoassay for vasopressin
The AVP radioimmunoassay was performed as previously de-
scribed (Correa et al., 2007). Brieﬂy, 1 mL plasma samples were
extracted using acetone/petroleum ether, lyophilized and stored at
−80 °C until analysis. Standard reagents and incubation protocols
were used for the peptide assays. For peptide labeling, 125I was pur-
chased from a commercial supplier (Amersham) and an AVP antise-
rum (Peninsula Lab.) was used at a ﬁnal dilution of 1:40,000 in a
phosphate buffer (pH 7.5) supplemented with BSA (0.5%). A non-
equilibrium assay was used with an incubation volume of 500 μL
and an incubation time of 4 days at 4 °C. Bound hormone was sepa-
rated from unbound by a secondary antibody produced in the labora-
tory of J. Antunes-Rodrigues and Lucila L.K. Elias (Univ. São Paulo,
Ribeirão Preto), where the RIA was performed. The AVP antiserum
is speciﬁc and shows essentially no cross-reactivity with oxytocin.
The minimum detection limit was 0.9 pg⁄mL and the coefﬁcients of
intra- and inter-assay variation were 7% and 11%, respectively.
2.7. Microdissection of the SON and PVN nuclei
In a cryostat, the brain was placed in a brain matrix (Insight Equip-
ment LTDA, Ribeirão Preto, Brazil) and cut based on rat brain atlas
coordinates (Swanson, 1998) with optic chiasm as anatomical land-
mark for reproducibility among the dissections. A single section of
approximately 1-mm thickness was taken and the PVN and SON re-
gions were carefully dissected by using punch needles of 1400 μm
and 1200 μm diameter, respectively (Palkovits, 1973).
2.8. Primer design, RNA extraction and reverse transcription
Gene-speciﬁc primers for rat caspase-3 (NM_012922.2), GAPDH
(NM_017008) and 18S (M11188) were designed based on GenBank
sequences. The sequences were as follows: caspase-3 (+) cag tgg
tgg aca tga cga c, (−) agt tgg tat tat ggt ctg tcc; GAPDH: (+) tca cca
cca tgg aga agg c, (−) gct aag cag ttg gtg gtg ca; 18S: (+) acg gaa
ggg cac cac cag ga and (−) cac cac cac cca cgg aat cg. The reference
gene (GAPDH and 18S) primer combinations had already been vali-
dated in previous studies (Oliveira-Pelegrin et al., 2010b).
The tissue punches were homogenized in 1 mL of TRIzol Reagent
(Invitrogen, Carlsbad, CA, USA) for total RNA extraction. All samples
were treated with RNase-free DNase I (Invitrogen, Carlsbad, CA,
USA) to remove any contaminating genomic DNA. RNA purity and
quantity were assessed by spectrophotometry using a Synergy H1
Take 3 system (BioTek) and Gen5 software. First-strand cDNA synthe-
sis was carried out using the following protocol. Two μg of total RNA,
1 μL of oligo(dT)12–18 primer (0.5 μg/μL, Invitrogen, Carlsbad, CA,
USA) and 1 μL of dNTP mix (10 mM) (Invitrogen, Carlsbad, CA,
USA) were incubated at 69 °C for 5 min and chilled on ice. Subse-
quently, 4 μL of 5× First Strand Buffer, 2 μL of DTT (0.1 M) and 1 μL
of RNaseOUT Ribonuclease Inhibitor (Invitrogen, Carlsbad, CA, USA)
were added and the samples incubated for 2 min at 42 °C. Next,
SuperScript™ II Reverse Transcriptase (200 U, Invitrogen, Carlsbad,
CA, USA) was added and the reaction incubated at 42 °C for 50 min
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until analysis. All cDNA samples were diluted 1:3 with DEPC-treated
water before being used as templates in quantitative PCR assays.
2.9. Quantitative real-time PCR (qPCR)
Quantitative real-time PCR studies were performed using Fast
EvaGreen Master Mix (BIOTIUM, Hayward, USA) in a Mastercycler
ep realplex (EPPENDORF, Hamburg, Germany). qPCR reactions,
performed in 96-well 0.2 mL thin-wall PCR microplates (AXYGEN)
sealed with ﬁlm, consisted of 10 μL of Fast EvaGreen Master Mix,
0.8 μL of each forward and reverse primer (10 μM), and 2 μL of
1:3-diluted template cDNA in a total volume of 20 μL completed
with DEPC-treated water. Cycling was performed using the optimized
conditions in a four-step experimental run protocol: (i) denaturation
program (2 min at 96 °C); (ii) ampliﬁcation and quantiﬁcation pro-
gram repeated 45 times (5 s at 96 °C, 5 s at 58 °C, 25 s at 72 °C);
melting curve program (60–95 °C with a heating rate of 0.5 °C/s
and continuous ﬂuorescence measurement); (iv) cooling program
down to 4 °C. Melting curveswere established after thermocycling to as-
sure that the primers produced a gene-speciﬁc product. The qPCR assays
for each gene included a negative control (without cDNA template). All
samples were run in triplicate. Standard curves for each pair of primers
(caspase-3, GAPDH, 18S) were prepared using serial 1:10 dilutions of a
positive control cDNA samples. Primer ampliﬁcation efﬁciency (E) was
calculated according to the equation: E = 10(−1/slope)− 1 (Bustin et
al., 2009). Non-manipulated animals were used as control, and the nor-
malization factor obtained from a combination of two different refer-
ence genes (GAPDH and 18S) was used to normalize gene expression
levels. Ampliﬁcation efﬁciencies, slopes, y-intercepts and correlation co-
efﬁcientswere obtained directly from theMastercycler ep realplex Soft-
ware showing similar E and correlation coefﬁcients for all analyzed
genes.
2.10. Western blot analysis for cleaved caspase-3
Hypothalamus tissue punches were place in RIPA buffer (R0278,
Sigma-Aldrich) with 10% of diluted 1:10 of protease inhibitor cocktail
(P2714, Sigma-Aldrich) and 0.5% of phenylmethylsulfonyl ﬂuoride
(PMSF, 78830, Sigma-Aldrich) 200 mM in methanol for homogeniza-
tion by sonication. After shaking for 2 h on ice, the samples were
centrifuged at 3500 ×g for 20 min at 4 °C. The total protein in the
supernatant was measured at 592 nm by using a bicinchoninic acid
(BCA) assay following manufacturer's instructions (Pierce BCA pro-
tein assay kit, #23225). Equal amounts of total protein (40 μg) were
diluted in 2× Laemmli buffer (S3401, Sigma-Aldrich) and separated
by SDS-PAGE in a 10% polyacrylamide gel (125 V for 1.5 h). Molecular
mass markers of 10–250 kDa (RPN800E GE Healthcare) were applied
on the gel to visualize separation and transfer quality. Following elec-
trophoresis, the proteins were blotted onto a nitrocellulose mem-
brane (0.45 μm; Millipore) in a tank blotting system. Western
blotting was performed under a current of 100 V for 2 h in transfer
buffer containing 20% methanol. After remaining in blocking solution
(5% bovine serum albumin [BSA] in 0.1 M phosphate buffered saline
[PBS] with 0.2% Tween20 (P5927, Sigma-Aldrich) [PBS-T]) for 1 h,
membranes were rinsed in PBS-T and then incubated overnight
under agitation at room temperature with speciﬁc antibodies diluted
in PBS-T with BSA 1%. For CC3 detection (17/19 kDa), a rabbit mono-
clonal IgG antibody speciﬁc for these large fragments of cleavage
caspase-3 (#9664, Cell Signaling) was used at a 1:500 dilution, and
β-actin detection (45 kDa) was done with a mouse monoclonal IgG
antibody (sc-47778 Santa Cruz Biotechnology) at a 1:5000 dilution.
Secondary HRP-conjugated antibodies (anti-rabbit [Abcam] for CC3
and anti-mouse [Santa Cruz Biotechnology] for β-actin) were diluted
1:10,000 in PBS-T with BSA 1%, and the membranes incubated under
agitation for 2 h at room temperature. A chemiluminescence reactionkit (enhanced chemiluminescence [ECL], GE Healthcare) and X-ray
ﬁlm was used for detection of proteins. X-ray ﬁlms were
photographed using a light box and image acquisition system and
the ECL-detected protein bands quantiﬁed by Genetools software
(Syngene, Cambridge, England). The results were transformed into
arbitrary units of optical density and normalized by β-actin levels
(internal control).
2.11. Immunohistochemistry for cleaved caspase-3
Free ﬂoating brain sections were washed 3 times in PBS (0.01 M,
pH 7.4) and immediately thereafter an antigen retrieval protocol
was performed in two steps: a 5 min incubation in a Tris/EDTA
(10 mM/1 mM, pH 9.0) solution, followed by heating for 30 min in a
water bath at 50 °C in 10 mM sodium citrate buffer (pH 6.0). After
reaching room temperature, the sections were washed in PBS for
15 min. Endogenous peroxidases were blocked by treatment with hy-
drogen peroxide (1% in PBS) for 10 min. After several rinses in PBS for
15 min, nonspeciﬁc binding sites were blocked for 60 min in PBS
containing 5% normal goat serum (NGS) and Triton X-100 (nonionic
detergent, T8532, Sigma-Aldrich). Subsequently, the sections were
incubated for 24 h at 4 °C with cleaved caspase-3 antibody (rabbit
monoclonal IgG, #9664 Cell Signaling) diluted 1:500 in PBS containing
1% BSA, 1% NGS and 0.3% Triton X-100. After rinsing, the sections were
incubated for 90 min at room temperature with biotinylated second-
ary antibody (goat anti-rabbit IgG, ABC Elite kit, Vectastain) diluted
1:2000 in PBS containing 1% BSA, 1% NGS and 0.3% Triton X-100.
After washing in PBS, the sections were placed in avidin–biotin perox-
idase complex for 30 min (ABC, Vectastain) and once again rinsed in
PBS before incubation with 0.05% 3-3′-diaminobenzidine (DAB) and
0.001% hydrogen peroxide for 10 min. Finally, the sections were
mounted on gelatin-coated slides, dehydrated and coverslipped with
Entellan (Merck). The sections were analyzed by light microscopy
and labeled neurons detected using a Zeiss KS300 microscope and
images captured using an AxioCam MRc system (Zeiss) coupled to
the microscope. The anatomical description of brain regions follows
that of Swanson (1998).
2.12. Statistical analysis
The data are presented as mean ± S.E.M. Statistical analysis
was performed by two-way analysis of variance (ANOVA) and a post
hoc Student–Newman–Keuls (SNK) test. mRNA relative expression
ratios were obtained from Relative Expression Software Tool-Multiple
Condition Solver (REST-MCS©-version 2) (Pfafﬂ et al., 2002) by using
threshold quantiﬁcation cycle (Cq) values which were signiﬁcantly
(10 times the standard deviation) above baseline noise. A positive
ratio means up-regulation and a negative one down-regulation. P
values ≤0.05 were considered as signiﬁcant.
3. Results
Alreadywithin the ﬁrst two hours, all animals submitted to CLP ex-
perimental sepsis developed the typical early clinical signs of sepsis,
including lethargy, piloerection and diarrhea. Sham animals remained
active in their cages, as expected.
Plasma cytokines were increased primarily in the early phase of
sepsis (4 and 6 h), with TNF-α plasma levels being signiﬁcantly
higher in the CLP group at 4 h only (P b 0.05), becoming undetectable
in both groups at 24 and 48 h (Fig. 1A). For IL-1β, plasma levels were
signiﬁcantly increased at both 6 and 24 h after CLP (P b 0.05, Fig. 1B).
IL-6 plasma levels were signiﬁcantly increased in the CLP group at 4
and 6 h (P b 0.05), and undetectable in both groups at 48 h (Fig. 1C).
Nitrate plasma levels increased progressively until 24 h after CLP,
with signiﬁcant differences between the sham and CLP group at 4, 6
and 24 h (P b 0.05) (Fig. 2A). AVP plasma levels on the other hand
Fig. 1. Cytokines plasma levels in sham-operated (white bar) and septic rats (black bar).
The results are expressed as mean ± SEM. Number of animals is shown in parenthesis.
Statistical analysis performed using ANOVA following by SNK test. A: TNF-α plasma
levels analysis showed effects of stimulus (F(1,65) = 6.91, P = 0.011), time (F(3,65) =
3.95, P = 0.012) and interaction (F(3,65) = 4.04, P = 0.011), with higher levels in the
septic group at 4 h. B: IL-1β plasma levels statistical analysis showed effect of stimulus
(F(1,108) = 14.90, P b 0.001) and time (F(3,108) = 3.01, P = 0.033), with differences
between sham and CLP at 6 and 24 h. C: IL-6 plasma levels statistical analysis showed
effect of stimulus (F(1,110) = 36.85, P b 0.001), time (F(3,110) = 12.64, P b 0.001) and
as well as interaction (F(3,110) = 11.57, P b 0.001), with signiﬁcant difference between
sham and CLP at 4 and 6 h. *P b 0.05 compared to sham group. No detectable values are
showed as nd.
Fig. 2. Plasma levels of nitrate (A) and vasopressin (B) in sham-operated (white bar)
and septic rats (black bar). The results are expressed as mean ± SEM. Number of ani-
mals is shown in parenthesis. Statistical analysis performed using ANOVA following
by SNK test. A: nitrate plasma levels statistical analysis showed signiﬁcant effect of
stimulus (F(1,41) = 40.50, P b 0.001), time (F(3,41) = 5.33, P = 0.003) and interaction
(F(3,41) = 4.18, P = 0.011), with differences between CLP and sham at 4, 6 and 24 h.
B: AVP plasma levels statistical analysis showed effect of stimulus (F(1,83) = 15.56,
P b 0.001) and interaction (F(3,83) = 4.97, P = 0.003), with differences between sham
and CLP at 4 and 6 h. *P b 0.05 compared to sham group. +P b 0.05 compared within
sham group.
Table 1
Fold change in caspase-3 transcript levels comparing to control group (non-manipulated
animals). Number of animals was 6 each group.
Group Time PVN SON
Sham 4 h 1.11 −1.00
6 h 1.12 −1.43
24 h 1.07 1.00
48 h 1.42 1.21
CLP-induced sepsis 4 h 1.16 1.06
6 h 1.09 1.22
24 h −1.05 −1.08
48 h 1.06 1.08
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P b 0.001) and, as expected, remained basal in the late phase (24 and
48 h) (Fig. 2B).Caspase-3 transcripts in the PVNand SONwere analyzed by qPCR, and
the relative gene expression ratio (R) ofmRNAwas calculated on the basis
of PCR efﬁciency (E) and quantiﬁcation cycle deviation (ΔCq) according
to the equation: R = (Etarget)ΔCq target(Mean control − Mean samples) /
(Eref)ΔCq ref(Mean control − Mean samples) (Pfafﬂ et al., 2002). No signiﬁ-
cant fold changes in caspase-3 transcript levels were noted in the PVN
and SON (Table 1).
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creased in both PVN and SON in septic animals. CC3 expression
started to increase at 4 h and 6 h, in the SON and PVN respectively,
and remained elevated until 48 h (P b 0.05) in both nuclei (Fig. 3).
The immunohistochemistry analysis clearly showed enhanced CC3
immunolabeling in both nuclei after CLP (Fig. 4).
4. Discussion
During polymicrobial sepsis pro-inﬂammatory cytokines and ni-
trate plasma levels were increased, and this was accompanied by ele-
vated CC3 protein levels in the two hypothalamic nuclei, PVN and SON.
This was put in evidence by a clear increase in CC3 immunolabeled
magnocellular neurons in both nuclei at 6 and 24 h after CLP. In the
control group we observed a weak immunostaining only, which
can be explained by possible other intracellular CC3 roles, besides
apoptosis induction. In fact, CC3 has been shown to be involved in
cell cycle regulation and differentiation, as well as the survival of astro-
cytes and Bergmann glial cells following cytotoxic damage (Schwerk
and Schulze-Osthoff, 2003; Villapol et al., 2008).
These results indicate that during sepsis magnocellular neurons in
the hypothalamus may undergo a deﬁcit of activity, including AVP
synthesis, which could contribute to the impairment in the secretion
of this hormone secretion in the late phase of sepsis. Furthermore, the
results on CC3 protein levels in the hypothalamus corroborate a pre-
vious observation showing a decrease in c-fos expression and AVPFig. 3. Cleaved caspase-3 protein expression. A: Western blot analysis of cleaved caspase-3 (
septic rats (CLP). B: Quantitative analysis of cleaved caspase-3 expression in the paraventric
The data show means ± S.E.M. of expression ratio between cleaved caspase-3 and β-actin
ANOVA following by SNK test. For the PVN statistical analysis showed signiﬁcant effect of
ences between CLP and sham at 6, 24 and 48 h. For the SON statistical analysis showed ef
at 4, 6, 24 and 48 h. *P b 0.05 compared to sham group. +P b 0.05 compared within the grmRNA in magnocells in the late phase of CLP-induced sepsis (Correa
et al., 2007; Oliveira-Pelegrin et al., 2010b). Taken together, these
changes contribute to our understanding of themechanisms responsi-
ble for the decrease in AVP secretion in this phase of polymicrobial
sepsis that contributes to hypotension and vasodilatory shock observed
in both experimental and clinical ﬁndings (Landry et al., 1997; Correa
et al., 2007; Russell, 2007; Pancoto et al., 2008; Oliveira-Pelegrin et al.,
2010b).
During sepsis, the complex interactions between host and infec-
tious agents result in a massive production of inﬂammatory media-
tors that could reach the central nervous system (CNS) through
circumventricular organs (CVOs), these being highly vascularized
structures lacking a blood–brain barrier and promoting bilateral com-
munication with the immune system (Wong et al., 1996, 1997; Rivest
et al., 2000). Endotoxins and cytokines passing CVOs may thus stimu-
late the expression of inﬂammatory mediators in the brain (Rivest et
al., 2000). Furthermore, TNF-α, IL-1β and IL-6 were shown to activate
the hypothalamic-pituitary and stimulate AVP secretion (Mastorakos
et al., 1994; McCann et al., 2000). IL-1β, besides stimulating AVP se-
cretion can also induce iNOS expression (Wong et al., 1996) and con-
sequently lead to an increase in NO levels that, consequently, may
cause an impairment in cellular bioenergetics and, further, result in
the activation of apoptotic pathways (Mignotte and Vayssiere, 1998;
Mander and Brown, 2004, 2005; Erusalimsky and Moncada, 2007).
An essential step in the activation of programmed cell death is the
cleavage of caspase 3 that can occur via both intrinsic and extrinsicCC3) and β-actin in the paraventricular (PVN) and supraoptic (SON) nuclei in sham and
ular (PVN) and supraoptic (SON) nuclei in sham (white bar) and septic rats (black bar).
. Number of animals is shown in parenthesis. Statistical analysis was performed using
stimulus (F(1,76) = 16.76, P b 0.001) and time (F(3,76) = 4.24, P = 0.008), with differ-
fect of stimulus (F(1,103) = 61.35, P b 0.001), with differences between sham and CLP
oup. M: marker in kDa.
Fig. 4. Photomicrographs illustrating cleaved caspase-3 immunoreactivity in coronal sections through the paraventricular (PVN) and supraoptic (SON) nuclei of control and septic
animals at 6 and 24 h. Images were obtained by light microscopy. The arrows show the immunostaining for cleaved caspase-3 in neurons. Original magniﬁcation: 20× and 100×.
Scale bar = 50 μm.
15G.R. Oliveira-Pelegrin et al. / Journal of Neuroimmunology 258 (2013) 10–16apoptosis pathways (Mignotte and Vayssiere, 1998; Porter and Janicke,
1999).
Even though these results suggest that the impairment in AVP
secretion is expected to be due to hypothalamic apoptosis, it is
worthy of note that this hormone alteration is not observed in all
experimental animals or septic patients. In fact, after osmotic stimula-
tion in the late phase of septic shock some patients may respond by
increasing AVP secretion, and thus are classiﬁed as “responders”
whereas in others, AVP secretion remains basal, and these are consid-
ered “nonresponders” (Siami et al., 2010). Thus the hypothesis is that,
nonresponders would be patients or in our case animals suffering
from compromised magnocellular neurons during sepsis, while re-
sponders would be those without hypothalamic impairment. Accord-
ingly, post mortem studies on some septic patients revealed apoptosis
in neurons related to cardiovascular autonomic centers, including
hypothalamic nuclei (Sharshar et al., 2003b). Herein, we provide evi-
dence from an animal model that CLP-induced sepsis may be accompa-
nied by increased plasma cytokine levels and enhanced CC3 expression
in magnocellular neurons of the PVN and SON, and we hypothesizethat this may be an important factor for explaining the observed inad-
equate AVP secretion in the late phase of sepsis.Acknowledgments
The authors thank Nadir M. Fernandes, Milene M. Lopes and
Marcelo E. Batalhão for technical assistance. José Antunes-Rodrigues
and Sérgio Akira Uyemura provided the infrastructure for the radioim-
munoassay and quantitative PCR, respectively. Financial support from
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) is
gratefully acknowledged.References
Alexander, J.J., Jacob, A., Cunningham, P., Hensley, L., Quigg, R.J., 2008. TNF is a key
mediator of septic encephalopathy acting through its receptor, TNF receptor-1.
Neurochem. Int. 52, 447–456.
Bantel, H., Schulze-Osthoff, K., 2009. Cell death in sepsis: a matter of how, when, and
where. Crit. Care 13, 173.
16 G.R. Oliveira-Pelegrin et al. / Journal of Neuroimmunology 258 (2013) 10–16Berg, R.M., Moller, K., Bailey, D.M., 2011. Neuro-oxidative-nitrosative stress in sepsis.
J. Cereb. Blood Flow Metab. 31, 1532–1544.
Bone, R.C., Sprung, C.L., Sibbald, W.J., 1992. Deﬁnitions for sepsis and organ failure. Crit.
Care Med. 20, 724–726.
Bruhn, F.H., Correa, P.B., Oliveira-Pelegrin, G.R., Rocha, M.J., 2009. Blocking systemic nitric
oxide production alters neuronal activation in brain structures involved in cardiovas-
cular regulation during polymicrobial sepsis. Neurosci. Lett. 453, 141–146.
Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R.,
Nolan, T., Pfafﬂ, M.W., Shipley, G.L., Vandesompele, J., Wittwer, C.T., 2009. The
MIQE guidelines: minimum information for publication of quantitative real-time
PCR experiments. Clin. Chem. 55 (4), 611–622.
Correa, P.B., Pancoto, J.A., de Oliveira-Pelegrin, G.R., Carnio, E.C., Rocha, M.J., 2007. Par-
ticipation of iNOS-derived NO in hypothalamic activation and vasopressin release
during polymicrobial sepsis. J. Neuroimmunol. 183, 17–25.
Erusalimsky, J.D., Moncada, S., 2007. Nitric oxide and mitochondrial signaling: from
physiology to pathophysiology. Arterioscler. Thromb. Vasc. Biol. 27, 2524–2531.
Kovacs, K.J., 2002. Neurohypophyseal hormones in the integration of physiological re-
sponses to immune challenges. Prog. Brain Res. 139, 127–146.
Landry, D.W., Levin, H.R., Gallant, E.M., Ashton Jr., R.C., Seo, S., D'Alessandro, D., Oz,
M.C., Oliver, J.A., 1997. Vasopressin deﬁciency contributes to the vasodilation of
septic shock. Circulation 95, 1122–1125.
Mander, P., Brown, G.C., 2004. Nitric oxide, hypoxia and brain inﬂammation. Biochem.
Soc. Trans. 32, 1068–1069.
Mander, P., Brown, G.C., 2005. Activation of microglial NADPH oxidase is synergistic
with glial iNOS expression in inducing neuronal death: a dual-key mechanism of
inﬂammatory neurodegeneration. J. Neuroinﬂammation 2, 20.
Mastorakos, G.,Weber, J.S., Magiakou, M.A., Gunn, H., Chrousos, G.P., 1994. Hypothalamic-
pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by
recombinant interleukin-6 in humans: potential implications for the syndrome of in-
appropriate vasopressin secretion. J. Clin. Endocrinol. Metab. 79, 934–939.
McCann, S.M., Kimura, M., Karanth, S., Yu, W.H., Mastronardi, C.A., Rettori, V., 2000. The
mechanism of action of cytokines to control the release of hypothalamic and pitu-
itary hormones in infection. Ann. N. Y. Acad. Sci. 917, 4–18.
Mignotte, B., Vayssiere, J.L., 1998. Mitochondria and apoptosis. Eur. J. Biochem. 252,
1–15.
Nemzek, J.A., Xiao, H.Y., Minard, A.E., Bolgos, G.L., Remick, D.G., 2004. Humane end-
points in shock research. Shock 21, 17–25.
Oliveira-Pelegrin, G.R., Ravanelli, M.I., Branco, L.G., Rocha, M.J., 2009. Thermoregulation
and vasopressin secretion during polymicrobial sepsis. Neuroimmunomodulation
16, 45–53.
Oliveira-Pelegrin, G.R., Aguila, F.A., Basso, P.J., Rocha, M.J., 2010a. Role of central NO-
cGMP pathway in vasopressin and oxytocin gene expression during sepsis. Peptides
31, 1847–1852.
Oliveira-Pelegrin, G.R., de Azevedo, S.V., Yao, S.T., Murphy, D., Rocha, M.J., 2010b. Cen-
tral NOS inhibition differentially affects vasopressin gene expression in hypotha-
lamic nuclei in septic rats. J. Neuroimmunol. 227, 80–86.Palkovits, M., 1973. Isolated removal of hypothalamic or other brain nuclei of the rat.
Brain Res. 59, 449–450.
Pancoto, J.A., Correa, P.B., Oliveira-Pelegrin, G.R., Rocha, M.J., 2008. Autonomic dysfunc-
tion in experimental sepsis induced by cecal ligation and puncture. Auton.
Neurosci. 138, 57–63.
Pfafﬂ, M.W., Horgan, G.W., Dempﬂe, L., 2002. Relative expression software tool (REST)
for group-wise comparison and statistical analysis of relative expression results in
real-time PCR. Nucleic Acids Res. 30, e36.
Porter, A.G., Janicke, R.U., 1999. Emerging roles of caspase-3 in apoptosis. Cell Death
Differ. 6, 99–104.
Rivest, S., Lacroix, S., Vallieres, L., Nadeau, S., Zhang, J., Laﬂamme, N., 2000. How the
blood talks to the brain parenchyma and the paraventricular nucleus of the hypo-
thalamus during systemic inﬂammatory and infectious stimuli. Proc. Soc. Exp. Biol.
Med. 223, 22–38.
Russell, J.A., 2007. Vasopressin in vasodilatory and septic shock. Curr. Opin. Crit. Care
13, 383–391.
Schwerk, C., Schulze-Osthoff, K., 2003. Non-apoptotic functions of caspases in cellular
proliferation and differentiation. Biochem. Pharmacol. 66, 1453–1458.
Semmler, A., Okulla, T., Sastre, M., Dumitrescu-Ozimek, L., Heneka, M.T., 2005. Systemic
inﬂammation induces apoptosis with variable vulnerability of different brain re-
gions. J. Chem. Neuroanat. 30, 144–157.
Sharshar, T., Blanchard, A., Paillard, M., Raphael, J.C., Gajdos, P., Annane, D., 2003a. Cir-
culating vasopressin levels in septic shock. Crit. Care Med. 31, 1752–1758.
Sharshar, T., Gray, F., Lorin de la Grandmaison, G., Hopkinson, N.S., Ross, E., Dorandeu,
A., Orlikowski, D., Raphael, J.C., Gajdos, P., Annane, D., 2003b. Apoptosis of neurons
in cardiovascular autonomic centres triggered by inducible nitric oxide synthase
after death from septic shock. Lancet 362, 1799–1805.
Sharshar, T., Annane, D., de la Grandmaison, G.L., Brouland, J.P., Hopkinson, N.S.,
Francoise, G., 2004. The neuropathology of septic shock. Brain Pathol. 14, 21–33.
Siami, S., Bailly-Salin, J., Polito, A., Porcher, R., Blanchard, A., Haymann, J.P., Laborde, K.,
Maxime, V., Boucly, C., Carlier, R., Annane, D., Sharshar, T., 2010. Osmoregulation of
vasopressin secretion is altered in the postacute phase of septic shock. Crit. Care
Med. 38, 1962–1969.
Swanson, L.W., 1998. BrainMaps: Structure of the Rat Brain. Elsevier Science, Amsterdam.
Villapol, S., Acarin, L., Faiz, M., Castellano, B., Gonzalez, B., 2008. Survivin and heat
shock protein 25/27 colocalize with cleaved caspase-3 in surviving reactive astro-
cytes following excitotoxicity to the immature brain. Neuroscience 153, 108–119.
Vincent, J.L., Korkut, H.A., 2008. Deﬁning sepsis. Clin. Chest Med. 29, 585–590 (vii).
Wong, M.L., Bongiorno, P.B., Al-Shekhlee, A., Esposito, A., Khatri, P., Licinio, J., 1996. IL-1
beta, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and
perivascular areas. Neuroreport 7, 2445–2448.
Wong, M.L., Bongiorno, P.B., Rettori, V., McCann, S.M., Licinio, J., 1997. Interleukin (IL)
1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central ner-
vous system and anterior pituitary during systemic inﬂammation: pathophysiolog-
ical implications. Proc. Natl. Acad. Sci. U. S. A. 94, 227–232.
